Lipohypertrophy - A complication of insulin injections [10]

South African Medical Journal

Volumn 95, Issue 11 I, 2005, Pages 858-859

  de Villiers, F P R ^a  

^a UNIVERSITY OF LIMPOPO   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

CHILDHOOD DISEASE; CLINICAL EXAMINATION; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; HUMAN; INJECTION SITE REACTION; LETTER; LIPOHYPERTROPHY; PATIENT COUNSELING; PRESCRIPTION; PREVALENCE;

ADIPOSE TISSUE; ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPERTROPHY; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; PALPATION; PATIENT EDUCATION; PREVALENCE;

EID: 28044458773     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (13)

1. Chowdhury TA, Escudier V. Poor glycaemic control caused by insulin induced lipohypertrophy. BMJ 2003; 327: 383-384.
2. Griffin ME, Feder A, Tamborlane WV. Lipohypertrophy associated with Lispro insulin in insulin pump therapy. Diabetes Care 2001; 24: 174.
3. Ampudio-Blasco FJ, Hasbum B, Carmena R. A new case of lipohypertrophy with Lispro insulin pump therapy. Is there any insulin preparation free of complications? Diabetes Care 2003; 26: 953-954.
4. Arranz, A, Andia V, López-Guzmán A. A case of lipohypertrophy with Lispro insulin without insulin pump therapy. Diabetes Care 2004, 27: 625-626.
5. McNally PG, Jowett NI, Kurinczuk JJ, Peck RW, Hearnshaw JR. Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins. Postgrad Med J 1988; 64: 950-853.
6. Kordonouri O, Lauterborn R, Diess D. Lipohypertrophy in young patients with type 1 diabetes. Diabetes Care 2002; 25: 634.
7. Raile K, Noelle V, Landgraf R, Schwartz HP. Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes 2001; 109: 393-396.
8. Hauner H, Stockamp B, Haastert B. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors. Exp Clin Endocrinol Diabetes 1996; 104: 106-110.
9. Ganda OP. Lipoatrophy, lipodystrophy and insulin resistance. Ann Intern Med 2000; 133: 304-305.
10. Arioglu E, Duncan-Morin J, Sebring N, et al. Efficacy and safety of troglitazone in the treatment of lipohypertrophy syndromes. Ann Intern Med 2000; 133: 263-274.
11. Roper NA, Bilous RW. Resolution of lipohypertrophy following change of short acting insulin to insulin lispro. Diabet Med 1998; 15: 1063-1064.
12. Hanas R, Stanke CG, Östberg H. Diagnosis of the cause of malfunction of indwelling catheters for insulin injections by the use of digital fluoroscopy. Pediatr Radiol 2000; 30: 674-676.
13. Young RJ, Hannan WJ, Frier BM, Steel JM, Duncan LJP. Diabetic lipohypertrophy delays insulin absorption. Diabetes Care 1984; 7: 479-480.